Dose response of intravenous heparin on markers of thrombosis during primary total hip replacement

Anesthesiology

Volumn 90, Issue 4, 1999, Pages 981-987

  Sharrock, Nigel E ^a   Go, George ^b   Sculco, Thomas P ^b   Salvati, Eduardo A ^b   Westrich, Geoffrey H ^b   Harpel, Peter C ^b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b NONE

Author keywords

Epidural anesthesia; Epinephrine; Fibrin generation

Indexed keywords

D DIMER; FIBRINOPEPTIDE A; HEPARIN; PROTHROMBIN; SODIUM CHLORIDE; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EPIDURAL ANESTHESIA; FEMALE; FEMUR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL RISK; THROMBOGENESIS; THROMBOSIS; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS;

AGED; ANTICOAGULANTS; ANTITHROMBIN III; ARTHROPLASTY, REPLACEMENT, HIP; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOPEPTIDE A; HEPARIN; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; POSTOPERATIVE COMPLICATIONS; THROMBOSIS;

EID: 0032900826     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199904000-00009     Document Type: Article

References (23)

1. Murray DW, Britton AR, Bulstrode CJK: Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg [Br] 1996; 78B: 863-70
2. Eriksson BI, Ekrnan S, Kälebo P, Zachrisson B, Bach D, Close P: Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996; 347:635-9
3. Colwell CW Jr, Spiro TE: Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty. Clin Orthop 1995; 319:215-22
4. FDA Public Health Advisory: Reports of Epidural or Spinal Hematomas with the Concurrent Use of Low Molecular Weight Heparin and Spinal/Epidural Anesthesia or Spinal Puncture. Rockville, MD, US Department of Health and Human Resources, December 15, 1997
5. Woolson ST, Watt JM: Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. J Bone Joint Surg [Am] 1991; 73A:507-12
6. Santori FS, Vitullo A, Stopponi N, Santori N, Ghera S: Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump. J Bone Joint Surg [Br] 1994; 76B: 579-83
7. Westrich GH, Sculco TP: Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg [Am] 1996; 78A:826-34
8. Comerota AJ, Katz ML, White JV: Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg 1992; 164:265-8
9. Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA: Thrombogenesis during total hip replacement. Clin Orthop 1995; 319: 16-27
10. Dahl OE, Andreassen G, Aspelin T, Müller C, Mathiessen P, Nyhus S, Abdelnoor M, Solhaug J-H, Arnessen H: Prolonged thromboprophylaxis following hip replacement surgery - Results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin®). Thromb Haemost 1997; 77:26-31
11. Sharrock NE, Salvati EA: Hypotensive epidural anesthesia for total hip arthroplasty. Acta Orthop Scand 1996; 67:91-107
12. Sharrock NE, Brien WW, Salvati EA, Mineo R, Garvin K, Sculco TP: The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis. A randomized, double-blind trial in patients operated on with epidural anesthesia and controlled hypotension. J Bone Joint Surg [Am] 1990; 72A:1456-61
13. Huo MH, Salvati EA, Sharrock NE, Brien WW, Sculco TP, Pellici PM, Mineo R, Go G: Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial. Clin Orthop 1992; 274:35-46
14. Hirsh J: Heparin. N Engl J Med 1991; 324:1565-74
15. Rapold HJ, de Bono D, Arnold AE, Arnout J, De Cock F, Collen D, Verstraete M: Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group. Circulation 1992; 85:928-34
16. Bombeli T, Mueller M, Haeberli A: Anticoagulant properties of the vascular endothelium. Thromb Haemost 1997; 77:408-23
17. Abildgaard U: Heparin/low molecular weight heparin and tissue factor pathway inhibitor. Haemostasis 1993; 23:103-6
18. Hirsh J, Levine MN: Low molecular weight heparin. Blood 1992; 79:1-17
19. Planès A, Vochelle N, Fagola M: Total hip replacement and deep vein thrombosis. J Bone Joint Surg [Br] 1990; 72B:9-13
20. Stewart GJ: Neutrophils and deep venous thrombosis. Haemostasis 1993; 23 (Suppl 1):127-40
21. Wessler S: Thrombosis in the presence of vascular stasis. Am J Med 1962; 33:648-66
22. Pellegrini VD Jr, Totterman S, Avers DC, Johanson N, Stulberg BN, Rosenberg A, Kessler C, Francis C: Comparison of a low molecular weight heparin and warfarin in prevention of deep vein thrombosis after total hip arthroplasty. Orthop Trans 1997; 21:124
23. Colwell CW Jr, Collis D, Paulson R, McCutchen J, Bigler G, Hardwick M, Hernandez R, Lutz S: Enoxaparin versus warfarin: Hospital management for prevention of DVT following total hip arthroplasty with inpatient and three month evaluation. Orthop Trans 1997; 21:125